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Structural changes in the BH3 domain of SOUL protein upon interaction with
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The SOUL protein is known to induce apoptosis by provoking the
mitochondrial permeability transition, and a sequence homolog-
ous with the BH3 (Bcl-2 homology 3) domains has recently been
identiﬁed in the protein, thus making it a potential new member
of the BH3-only protein family. In the present study, we provide
NMR, SPR (surface plasmon resonance) and crystallographic
evidencethatapeptidespanningresidues147–172inSOULinter-
acts with the anti-apoptotic protein Bcl-xL. We have crystallized
SOUL alone and the complex of its BH3 domain peptide with
Bcl-xL, and solved their three-dimensional structures. The SOUL
monomerisasingledomainorganizedasadistortedβ-barrelwith
eight anti-parallel strands and two α-helices. The BH3 domain
extends across 15 residues at the end of the second helix and
eight amino acids in the chain following it. There are important
structural differences in the BH3 domain in the intact SOUL
molecule and the same sequence bound to Bcl-xL.
Key words: apoptosis, Bcl-xL, Bcl-2 homology 3 domain
(BH3 domain), crystal structure, NMR, SOUL, surface plasmon
resonance.
INTRODUCTION
The Bcl-2 family are a group of evolutionarily conserved proteins
that interact to maintain a balance between newly forming and
old, damaged or superﬂuous dying cells. [1]. They play a central
role in the regulation of apoptosis, or programmed cell death,
a process that in multicellular organisms leads to the controlled
death of unneeded or unwanted cells. A crucial event in apoptosis
is the MPT (mitochondrial permeability transition), a drastic
increase in the permeability of the mitochondrial inner membrane
to low-molecular-mass solutes [2]. Through the regulation of
apoptosis, the Bcl-2 proteins have an important function in
embryogenesis [3], tissue remodelling [4] and the immune
response[5].Theirabnormalbehaviourislinkedtomanydiseases,
such as autoimmunity [6], neurodegenerative disorders [7] and
cancer [8].
The effect of the Bcl-2 proteins on the apoptotic process
is due to the presence of one or more conserved regions of
amino acid sequences, known as BH (Bcl-2 homology) domains,
named BH1, BH2, BH3 and BH4 [9,10]. The proteins of this
family that contain only the BH3 domain are pro-apoptotic and
function as initial sensors of apoptotic signals resulting from
various cellular processes, whereas the pro-survival Bcl-2 family
members, such as Bcl-2 or Bcl-xL, wield their effect by binding
and sequestering their pro-apoptotic counterparts [11]. Peptides
spanning the sequence of BH3 domains appear to exert the
physiological activity of the intact proteins and their complexes
with anti-apoptotic members of the Bcl-2 family have received
considerable attention since this interaction is believed to explain
the effect at the molecular level. In particular, the complexes of
peptides with the sequences of the BH3 domains of Bad, Bim,
Bak, Bid and Beclin 1 with Bcl-xL have been examined by X-ray
crystallography and NMR, and the conserved crucial interactions
between the peptides and the protein have been identiﬁed [12,13].
Cancercellsfrequentlyoverexpresstheanti-apoptoticmembers
of the Bcl-2 family, and small molecules that incorporate the
structural features of the BH3 domains necessary for binding to
these anti-apoptotic proteins have been synthesized and are being
tested as speciﬁc cancer cell killers [14].
SOUL was ﬁrst identiﬁed at the transcriptional level by
suppression subtractive hybridization in the chicken retina and
pineal gland, and its gene was named ckSoul because of the
high transcript levels found in the pineal gland, the organ Ren´ e
Descartes hypothesized was the location of the soul [15]. A few
years before this report, human SOUL had been isolated and
characterized from saline extracts of human term placentas
and had been called PP23 (placental protein 23) [16]. More
recently, the protein has also been identiﬁed in human amniotic
ﬂuid [17]. It has subsequently been shown that the gene coding
for this protein is very widely distributed in evolution and it has
been characterized in many other species, including the popular
model organism of plant biology Arabidopsis thaliana.O nt h e
basis of its sequence similarity with the mouse gene p22HBP,
which codes for HEBP1 (haem-binding protein 1) or p22HBP,
SOUL has also been called the alternative name of HEBP2 [18].
Recombinant mouse SOUL was reported to be a dimer in the
absence of haem and to hexamerize upon haem binding, with a
dissociation constant in the nanomolar range [19].
A very important observation is that SOUL can induce the
MPT, a condition that leads to mitochondrial swelling and cell
death [20]. More recently, analysis of the human SOUL sequence
revealed the presence of a putative BH3 domain of the Bcl-2
protein family whose deletion abolished the apoptotic effects of
SOUL [21].
In the present paper, we provide experimental evidence that
SOUL is a BH3-only protein as the sequence spanning amino
acids 147–172 interacts with the anti-apoptotic protein Bcl-xL. In
addition, we have crystallized both intact SOUL and the complex
Abbreviations used: BH, Bcl-2 homology; HEBP, haem-binding protein; HSQC, heteronuclear single-quantum coherence; MPT, mitochondrial
permeability transition; rmsd, root mean square deviation; RZPD, Deutsches Ressouroenzentrum f¨ ur Genomforschung; SPR, surface plasmon resonance.
1 To whom correspondence should be addressed (email monaco@sci.univr.it).
The co-ordinates of the models, and the structure factors of SOUL and of the complex of human Bcl-xL with the peptide have been deposited in the
PDB under accession codes 3R85, 3R8J and 3R8K.
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of a peptide that contains its BH3 domain with Bcl-xL, and
solved their three-dimensional structures to 1.6 and 2.0 Å (1 Å =
0.1 nm) resolution respectively. The Bcl-xL–SOUL BH3 domain
interactions are particularly interesting, since the domain adopts
a different structure when bound to Bcl-xL.
EXPERIMENTAL
Protein expression and puriﬁcation
The cDNA coding for human SOUL (IMAGE ID 3445763),
obtained from RZPD (Deutsches Ressourcenzentrum f¨ ur
Genomforschung), was ampliﬁed by PCR using primers
designed to introduce restriction sites for BamHI and HindIII
endonucleases and a sequence coding for a digestion site for
thrombin in the C-terminal end in the ampliﬁed fragment.
After puriﬁcation, the fragment and the expression vector
pQE50 (Qiagen) were digested with the restriction enzymes
mentioned above and incubated with ligase to insert the cDNA
into the vector respecting the reading frame. BL21 C41 strain
Escherichia coli cells were transformed with the resulting vector,
grown at 37◦C and protein synthesis was induced overnight at
20◦C with 0.5 mM IPTG (isopropyl β-D-thiogalactopyranoside).
Under these conditions of subcloning in pQE50, the expressed
intracellular domain is fused to a histidine tag at its C-terminus.
The presence of the tag allowed the afﬁnity puriﬁcation of the
fused protein by passing the bacterial extracts through a nickel–
Sepharose column. The column was equilibrated with 20 mM
Tris/HCl (pH 7.5), 0.5 M NaCl, 10 mM imidazole and 0.02%
sodium azide, and the bound protein was eluted with a linear
gradient of imidazole from 10 to 500 mM. After the afﬁnity
column separation, the tag was removed by thrombin digestion
andtheproteinwaspuriﬁedfurtherbygelﬁltrationonaSuperdex
G-200 column equilibrated with 20 mM Tris/HCl (pH 7.5),
0.15 M NaCl and 0.02% sodium azide and by hydrophobic
interaction chromatography (Lipidex1000).
Recombinant human Bcl-xL (IMAGE ID 2823498; RZPD)
was prepared in a similar way. A truncated form lacking the
ﬂexible loop spanning amino acids 27–82 and the last 24 amino
acids, whicharethetransmembrane domain,wasinserted into the
pET15bvectorwhichintroducesanN-terminalhistidinetaganda
thrombin digestion sequence. The puriﬁcation protocol followed
that of SOUL.
Complete removal of the tag was assessed by Western blot
analysis using an HRP (horseradish peroxidase)-conjugated anti-
His antibody (Sigma–Aldrich). The puriﬁed protein was a single
band by SDS/PAGE in both cases.
UV–visible spectra were recorded with a UV/Vis Unicam
spectrometer. An aliquot of 250 μM haemin dissolved in DMSO
was diluted with 20 mM Tris/HCl (pH 7.5) and 0.15 M NaCl to
give a ﬁnal haemin concentration of 10 μM. The concentration
of the haemin solution was determined as described previously
[22]. Two other samples were prepared by adding, in addition
to haemin, appropriate aliquots of SOUL and BSA dissolved in
20 mM Tris/HCl (pH 7.5) and 0.15 M NaCl to bring their ﬁnal
concentration to 100 μM. These samples thus contained a ratio of
ten times the molar concentration of SOUL and BSA with respect
tothehaeminconcentration.Thethreesampleswereincubatedfor
30 min at room temperature (25◦C) and their UV–visible spectra
were recorded.
NMR measurements
For the production of
15N-labelled human Bcl-xL lacking only
the C-terminal transmembrane domain, host cells were grown
in M9 minimal medium using
15NH4Cl as sole nitrogen source.
HSQC (heteronuclear single-quantum coherence) NMR spectra
were recorded on a Bruker Avance spectrometer operating at
600.13 MHz, equipped with a cryoprobe. The labelled protein,
dissolved in 20 mM Tris/HCl (pH 7.5) and 0.15 M NaCl (in 10%
2H2O) and at a concentration of 85 μM, was titrated with the
SOUL BH3 peptide dissolved in the same buffer at 600 μM.
Nine additions were made so that, after correcting for the precise
peptide concentration and taking into account dilutions, the
BH3 peptide/protein molar ratio was 0.07, 0.17, 0.26, 0.35, 0.52.
0.69, 1.38, 2.77 and 3.83. After each of the additions, the sample
was incubated at 20◦C for approximately 5 min and a one-
dimensional
15N-decoupled
1H spectrum and a two-dimensional
1H-
15N HSQC spectrum were recorded at the same temperature.
Standardsequenceschemeswithpulsed-ﬁeldgradientswereused
to achieve the suppression of the solvent signal.
The dissociation constant was calculated from the shifts in two
peaks in fast exchange in the methyl region of the decoupled
1H
spectrum ﬁtting the data with the equation:
  =  max

(P + L + Kd) −
√
{(P + L + Kd)2 − 4PL}

2P
where   is the chemical shift change, P is the protein
concentration, L is the total ligand concentration, and Kd is the
dissociation constant. Appropriate corrections for the dilution of
protein and ligand were made after the addition of each aliquot
during the titration.
SPR (surface plasmon resonance) studies
Bcl-xL was immobilized on a COOH1 research-grade sensor
chip (Nomadics) by amine-coupling chemistry using the
manufacturer’s protocols, and the SOUL BH3 domain peptide
was used as the analyte. SPR measurements were carried out in
HBSbuffer[10 mMHepes(pH 7.4),150 mMNaCl,3 mMEDTA
and 0.005% P-20 surfactant] at 20◦C using a SensiQ Pioneer
instrument (ICx Technologies). Data were analysed with the Qdat
evaluation analysis software.
Crystallization, X-ray data collection, structure solution and
reﬁnement
PuriﬁednativeSOULwasusedatapproximately20 mg/mlforthe
initial screen of crystallization conditions. Molecular Dimensions
Structure Screens were used at 20◦C with the hanging-drop
method,mixing1 μloftheproteinsolutionwiththesamevolume
oftheprecipitatingsolution,andequilibratingagainstavolumeof
0.3 ml of the latter in the reservoir. The conditions yielding small
crystals were later reﬁned and the sitting-drop method with larger
volumes was also tested until crystals that were large enough for
data collection were obtained.
The SOUL BH3 peptide spanning amino acids 147–172 was
synthesized by TAG Copenhagen. The complex of recombinant
human Bcl-xL with the peptide was prepared by mixing the
protein at approximately 4 mg/ml with four times the molar ratio
of the peptide. The mixture was incubated for about 1 h and then
concentrated to approximately 15 mg/ml, and was then used at
this concentration for the crystallization experiments.
TwodifferentcrystalformsofnativeSOULwereobtained,both
in the presence of 0.2 M 1-butyl-3-methylimidazolium chloride,
because it drastically improved the diffraction properties of the
crystals. The ﬁrst crystal form is hexagonal, space group P6122
with a = b = 143.9 Å and c = 242.1 Å. It contains four
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Table 1 Data collection and reﬁnement statistics
The values in parentheses refer to the highest resolution shells. For the data collection of the orthorhombic form, the highest resolution interval is 1.69–1.60 A ˚ and for the hexagonal form is
3.00–2.85 A ˚, whereas for the co-crystals of the BH3 domain with Bcl-xL it is 2.05–1.95 A ˚. The highest resolution shells used in the reﬁnements are: 1.66–1.60 A ˚, 2.95–2.85 A ˚ and 1.98–1.95 A ˚ for
the co-crystals of the BH3 domain. The ligand of the SOUL crystals is phosphate and that of the complex is sulfate.
Parameter Human SOUL native Human SOUL native Complex human Bcl-xL–human SOUL BH3 peptide
Space group C2221 P6122 P43
a (A ˚) 137.72 143.92 66.83
b (A ˚) 114.66 143.92 66.83
c (A ˚) 67.42 242.12 175.22
α (◦) 90.0 90.0 90.0
β (◦) 90.0 90.0 90.0
γ (◦) 90.0 120.0 90.0
Molecules in the asymmetric unit (n)2 4 4
Resolution range (A ˚) 24.9–1.60 80.0–2.85 53.1–1.95
Observed reﬂections (n) 470976 723081 276588
Independent reﬂections (n) 69663 35317 54709
Multiplicity 6.8 (6.5) 20.5 (20.4) 5.1 (5.2)
Rmerge (%)* 6.5 (38.1) 8.5 (38.8) 7.3 (32.0)
I/σ 18.3 (4.6) 25.7 (8.3) 17.6 (6.0)
Completeness (%) 98.9 (98.0) 99.9 (100.0) 98.0 (96.5)
Reﬂections in reﬁnement (n) 69648 35223 54700
Rcryst (%)† 17.5 23.5 21.1
Rfree (%) (test set 5%)‡ 19.7 26.8 26.3
Protein atoms (n) 2974 5631 5132
Ligand atoms (n) 5 (phosphate) − 5 (sulfate)
Water molecules (n) 395 − 172
rmsd on bond lengths (A ˚)§ 0.008 0.008 0.009
rmsd on bond angles (◦) 1.250 1.169 1.124
Planar groups (A ˚) 0.006 0.006 0.004
Chiral volume deviation (A ˚3) 0.081 0.074 0.068
Average B-factor (A ˚2) 21.2 73.3 36.4
Protein atoms 20.1 73.3 36.8
Ligand atoms 26.7 − 49.2
Solvent atoms 29.4 − 27.3
*Rmerge=

h

i|Iih− Ih |/

h

i Ih , where  Ih  is the mean intensity of the i observations of reﬂection h.
†Rcryst=

||Fobs|−|Fcalc||/

|Fobs|, where Fobs and Fcalc are the observed and calculated structure factor amplitudes respectively; summation includes all reﬂections used in the reﬁnement.
‡Rfree=

||Fobs|−|Fcalc||/

|Fobs|, evaluated for a randomly chosen subset of 5% of the diffraction data not included in the reﬁnement.
§rmsd from ideal values.
molecules in the asymmetric unit (see Table 1), diffracts to
approximately 2.85 Å and appears to be closely related to another
crystal form reported in the literature [23]. The crystals grow by
adding equal volumes of the protein solution and 0.1 M Tris/HCl
(pH 8.5) and 2.0 M ammonium sulfate. The second crystal form
is orthorhombic, space group C2221,a n da = 137.7 Å, b =
114.7 Å and c = 67.4 Å, and grows by mixing equal volumes of
the protein solution and 0.85 M NaH2PO4,K H 2PO4 and 0.08 M
Hepes (pH 7.5). These crystals diffract to a better resolution,
approximately 1.6 Å, contain two molecules in the asymmetric
unit and are the crystal form that was solved ﬁrst using the S.I.R.
(single isomorphous replacement) method. The hexagonal crystal
form was solved later by molecular replacement.
The best crystals of the complex human Bcl-xL–SOUL
BH3 peptide grew by mixing equal volumes of the complex
solution and 15% PEG [poly(ethylene glycol)] 6000, 0.2 M
sodium sulfate and 0.3 M 1-butyl-3-methylimidazolium 2-(2-
methoxyethoxy)ethyl sulfate. They are tetragonal, space group
P43, with a = b = 66.8 Å and c = 175.2 Å, and diffract to 2.0 Å
resolution.
The diffraction data were collected from crystals frozen at
100 K after a brief immersion in a mixture of 80% of the
mother liquor and 20% glycerol. The data set for a gold heavy
atom derivative used for phasing were obtained using copper Kα
radiation from a Rigaku RU-300 rotating anode X-ray generator
withaMar345imagingplateareadetector.Theﬁnaldatasetsused
for reﬁnement of this and the other crystal forms were collected
at the ID14-2 beamline of the ESRF (European Synchrotron
Radiation Facility) in Grenoble (λ = 1.001 Å). The data were
indexed, integrated and reduced using the programs AUTOMAR,
MOSFLM and Scala [24]. The diffraction data statistics of the
data sets used for reﬁnement are summarized in Table 1.
Initialphasesfortheorthorhombiccrystalstoa2.3Åresolution
were determined by the single isomorphous replacement method
with the derivative data collected at the home source. Two gold
siteswerelocatedinadifferencePattersonmapusingtheprogram
SHELXS [25] and entered as input for the program autoSHARP
[26] that was used to locate the minor sites of the derivative, and
fordensitymodiﬁcationandﬁnalphasingto1.8Åresolution.The
electron density map thus produced was of very good quality and
could be readily interpreted. The initial model of SOUL was built
in this map using the program Coot [27].
Reﬁnement was carried out initially using the program
REFMAC [28] and, in a second stage, with the program Phenix.
reﬁne [29]. During the process of reﬁnement and model building,
the quality of the models was controlled with the program
PROCHECK [30]. Solvent molecules were added to the model in
the ﬁnal stages of reﬁnement according to hydrogen-bond criteria
and only if their B factors reﬁned to reasonable values and if
they improved the Rfree. The model was ﬁnally subjected to a ﬁnal
round of TLS reﬁnement.
ThestructureofthehexagonalcrystalformofSOULwassolved
usingtheCCP4suiteofprogramsforcrystallographiccomputing.
The initial phases were calculated by the molecular replacement
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Figure 1 Overall structure and folding of SOUL
(A) Stereodiagram of the SOUL molecule. The eight-stranded β-sheet is shown in two colours, red and blue, to emphasize the presence of two repeated units, each with β-β-α-β-β topology,
related by a pseudo-two-fold axis of symmetry. (B) A topological diagram of SOUL. The eight antiparallel β-strands form a distorted β-barrel with the two α-helices arranged on one face. Strands
are labelled in the order of their appearance from the N-terminus to the C-terminus using the letters A–H. The eight strands span the following residues: A, 39–43; B, 46–55; C, 89–94; D, 103–110;
E, 127–132; F, 135–142; G, 174–178; H, 190–195. The two helices span residues 58–73 and 148–164. (C) Ribbon representation of the SOUL monomer viewed in a direction rotated approximately
90◦ with respect to (A). The two helices are in yellow, and the strands of the β-sheet have been coloured as (A and B) to emphasize the presence of the pseudo-two-fold axis. (D) Ribbon diagram
of SOUL with the peptide spanning the BH3 domain represented in light blue for the portion of the chain identiﬁed by sequence similarity with known BH3 domains and in yellow for the rest of the
second helix of the molecule. (E) Ribbon diagram of the NMR model of BID (lowest energy structure, PDB code 2BID) with the BH3 peptide and domain oriented and colour-coded as in (D). The
Figures of the models were prepared using the program PyMOL (http://www.pymol.org).
method as implemented in the program MOLREP [31], with the
co-ordinates of the orthorhombic model as the search probe.
The automatic search with data up to a resolution of 2.9Å gave
a solution that placed in their correct position three out of the
four molecules present in the asymmetric unit. Fixing these co-
ordinates, the fourth molecule was found by the same program.
The score of this solution was 0.544 and its R factor was 41.6%.
A similar procedure was followed to solve and reﬁne the
structureofthecomplexhumanBcl-xL–SOULBH3peptideusing
the co-ordinates of a protomer of Bcl-xL ([32]; PDB code 2YXJ)
as the search probe. After the four protomers of Bcl-xL present in
the asymmetric unit had been placed in their correct position, it
became evident that they dimerized with domain swapping and,
at this point, the extra electron density for the four BH3 helices
present in the asymmetric unit was also very clear. The ﬁnal
reﬁnement statistics for the models of the three crystal forms are
summarized in Table 1.
RESULTS
X-ray structure of human SOUL
The SOUL monomer is a single domain structure organized as an
opendistortedβ-barrelwitheightanti-parallelstrands.Thebarrel
is open in the sense that the ﬁrst and the last strands (A and E) are
not in contact in the sheet (Figure 1). Two α-helices connect the
second to the third strand and the sixth to the seventh strand. They
are both located on one face of the molecule and pack against
the curved sheet that forms the barrel. A monomer of SOUL ﬁts
into a box with the approximate dimensions 56×47×40 Å. This
fold is quite different from that of the canonical member of the
BH3-only protein family BID (Figure 1).
Examinationofthesecondarystructure(Figure1B)revealsthat
the molecule is made up of two repeated units, each with β-β-α-
β-β topologyrelatedbyapseudo-two-foldaxisofsymmetry.Two
SOUL monomers (A and B) are present in the asymmetric unit of
the orthorhombic crystal form (Table 1). The secondary structure
assignments of monomer A are, for the β-strands, the following:
strand A, residues 39–43, B, residues 46–55, C, residues 89–94,
D, residues 103–110, E, residues 127–132, F, residues 135–142,
G, residues 174–178 and H residues 190–195. The two α-helices
span residues 58–73 and 148–164. In addition, residues 25 and
26 extend the β-sheet and residues 113–116 form an additional
helix turn in both monomers. A minor difference between the two
monomers was also observed: strand D of molecule B has one
residue less at the N-terminal end.
The space within the β-barrel is ﬁlled by the side chains of
both hydrophobic and hydrophilic residues: Trp
48, Met
135,L e u
137,
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Leu
139 and Trp
193,b u ta l s oA r g
41 and Arg
132,A s p
130,A s p
191,
Thr
90 and Tyr
179. Packing of the ﬁrst helix takes place through
hydrophobic residues and the following speciﬁc contacts: Trp
58
(NE1)–Ser
91 (OG), Lys
68 (O)–Glu
124 (OE), Tyr
72 (OH)–Pro
120
(O), Tyr
72 (O)–Gln
77 (OE) and Ile
73 (O)–Ile
83 (N). Packing of
the second helix involves the following speciﬁc contacts: Gln
154
(OE)–Arg
140 (NE) and Leu
162 (O)–Lys
167 (N).
Two NMR structures of murine p22HBP have been
published [33,34]. The protein has approximately 28% sequence
identity with murine SOUL. Comparison of the two SOUL
molecules present in the crystallographic asymmetric unit of the
orthorhombic crystal form with the two NMR models of murine
p22HBP revealed that the four models differ substantially
only in rather limited areas (Supplementary Figure S1 at
http://www.BiochemJ.org/bj/438/bj4380291add.htm). The zone
where the two SOUL molecules in the asymmetric unit differ
more from one another are the region before the ﬁrst strand of
the β-sheet and the loop connecting strands C and D. The chains
before the ﬁrst strand are totally exposed to the solvent, whereas
in the case of the connection of strands C and D the loop in chain
A is in close contact with a symmetry-related molecule, and the
equivalentareainmoleculeBisincontactwiththesolvent.These
differences are thus probably simply a consequence of molecular
packing in the crystal. Although there is more variability in the
two NMR structures of murine p22HBP, the two models are very
similarintheregionconnectingstrandsCandD,whichisalsothe
region where both are most different from SOUL. This particular
region of the SOUL molecule thus appears to be more variable
than the rest of the molecule.
The BH3 domain predicted by sequence alignment to be
present in SOUL spans residues 158–172, i.e. the last seven
residues of the second α-helix of the molecule and eight amino
acids in the loop connecting it to strand G. The domain is
represented in light blue in Figure 1(D). Additional details on
this structure have been included as Supplementary information
(at http://www.BiochemJ.org/bj/438/bj4380291add.htm).
Does SOUL bind haemin?
All our attempts to prepare co-crystals of SOUL and haemin
failed. When crystallizations were set up, with haemin/SOUL
molar ratios of even up to ﬁve, the crystals obtained, after
screening many different conditions, were invariably those of
the apo protein. Soaking the pre-formed crystals did not reveal
any electron density other than that of the apo protein. It
was thus suspected that the interaction of the two molecules,
if present, was not as strong as expected. For this reason,
the UV–visible spectrum of haemin was examined alone and
in the presence of ten times the molar ratio of SOUL,
with BSA used as a control (Supplementary Figure S2A at
http://www.BiochemJ.org/bj/438/bj4380291add.htm). Although
the sample containing BSA had, due to the ligand–protein
interaction, its peak higher and shifted from 390 to 401 nM,
as expected for haemin bound with no axial co-ordination to
a hydrophobic cavity [35], the sample containing SOUL showed
onlynegligibledifferencesthatcanbeexplainedbytheabsorption
of the protein present in the sample and cannot be considered as
evidence of a SOUL–haemin interaction.
A second control was carried out recording
15N-
1HH S Q C
NMR spectra of
15N-labelled SOUL in the presence of increasing
amounts of haemin dissolved in Tris/HCl buffer. Haemin aliquots
corresponding to 0.5, 1, 2, 3 and 4 equivalents of SOUL were
added to the protein sample and the spectra were recorded at
25◦C (Supplementary Figure S2B). After the addition of up to
four equivalents of haemin per protein molecule, the spectrum
remainedunaltered.Giventhetimeinvolvedtorecordthedifferent
spectra, a kinetic effect can be excluded in this case or at least if
there was such an effect it has to be proposed that the reaction is
so slow that, even after more than 1 dayof observation,no change
in the spectrum is detectable at all. These observations thus lead
to the conclusion that, with the methods described in the present
study, no interaction between haemin and SOUL, that may be
considered of physiological relevance, can be observed.
Interaction of the SOUL BH3 peptide with human Bcl-xL
The BH3 domain predicted by sequence alignment to be present
in SOUL spans residues 158–172, i.e. the last seven residues
of the second α-helix of the molecule and eight residues in the
loop connecting it to strand G. BH3 domains are known to be
helical and, since we knew that in the structure of SOUL the
helix began before, we decided to examine the interaction of
a 26-amino-acid-long peptide spanning residues 147–172 with
the anti-apoptotic protein Bcl-xL, i.e. covering the entire helix
and the region predicted to be part of the BH3 domain by
sequence homology. The sequence of the peptide studied is:
SAQKNQEQLLTLASILREDGKVFDEK.Figure1(D)showsthe
SOUL monomer with the BH3 peptide coloured light blue for
thechainpredictedtobepartofthedomainbysequencealignment
and yellow for the rest of the peptide corresponding to the N-
terminal portion of the second α-helix of SOUL.
The interaction of the peptide and the protein was examined
in solution by one- and two-dimensional NMR and by SPR.
Figure 2(A) shows the amidic region of the
15N-
1HH S Q C
NMR spectrum of
15N-labelled human Bcl-xL (lacking the
transmembrane domain after amino acid 209) titrated with
increasing amounts of the peptide. Note the signiﬁcant changes
in some of the peaks of the protein as the interacting BH3
peptidewasaddedtothesolution.Figure2(B)showsthechemical
shift displacements in the two peaks in fast exchange in the
methyl region of the
1H spectrum that were used to calculate
an approximate dissociation constant of the interaction, and
Figure 2(C) shows the ﬁtting of these displacements as a function
ofequivalentsoftheBH3peptideadded.Thedissociationconstant
valuescalculatedusingthetwopeaksareinreasonableagreement
with one another and are 47.8 and 41.3 μM( s e eF i g u r e2 C ) .
The SOUL BH3 peptide–Bcl-xL interaction was also studied
by SPR. Both intact Bcl-xL and a form lacking amino acids 27–
82 ( 27–82) that is known to bind BH3 domains like the intact
protein [36] were immobilized on a sensor chip and the SOUL
BH3 domain peptide was used as the analyte. Similar results
conﬁrming the interaction were observed for both variants of
Bcl-xL. Figure 2(D) shows a sensorgram of the  27–82 form
of the protein. The dissociation constant estimated with this
method is approximately ﬁve times the value observed in the
NMR experiments. The discrepancy is probably due to errors in
the estimate of the peptide concentration used in the experiments.
However, we did not detect signiﬁcant binding between intact
SOUL and Bcl-xL (results not shown), which may reﬂect either a
lack of interaction under the conditions tested or more probably
the requirement of drastic structural changes in SOUL.
X-ray structure of the SOUL BH3 domain peptide complexed with
Bcl-xL
The data collection and reﬁnement statistics of the co-crystals
of human Bcl-xL ( 27–82) with the SOUL BH3 peptide are
summarized in Table 1. The crystals are tetragonal, space group
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Figure 2 Interaction of the SOUL BH3 peptide with human Bcl-xL
(A) 15N-1H NMR correlation spectra of 15N-labelled human Bcl-xL titrated with increasing amounts of a 26-amino-acid-long peptide spanning residues 147–172 of human SOUL. The peptide
sequence is SAQKNQEQLLTLASILREDGKVFDEK. Arrows indicate the direction of peak shifts. Only four spectra are represented in the Figure; the black one is before any addition, the green after the
addition of 0.52 equivalents of the peptide, the blue after the addition of 1.38 equivalents and the red after adding 3.83 equivalents of the BH3 domain peptide. (B) Decoupled 1H spectrum showing
the shifts in two peaks in fast exchange in the methyl region used to calculate an approximate dissociation constant. The colour of the spectra is the same as in (A) and corresponds to the addition
of the same amounts of peptide. (C) Magnitude of the change in the 1H chemical shift of the two selected peaks plotted as a function of the total number of equivalents of BH3 domain peptide added.
The best ﬁt curve is shown along with the coefﬁcient of determination (R2) and the calculated dissociation constants. The values determined using the two peaks are 47.8 and 41.3μM. The equation
used to ﬁt the data is given in the Experimental section. (D) SPR studies of the same interaction. The sensorgram shows the binding of the BH3 peptide to truncated immobilized Bcl-xL. Relative
units (RU) are plotted as a function of time (in s). (E) A plot of the response as a function of the peptide concentration used to estimate the dissociation constant. The diagram is the result of several
experiments and higher peptide concentrations could not be used because the BH3 peptide had a tendency to aggregate.
P43 and present 50% merohedral twinning. The structure was
solvedbymolecularreplacement,initiallyassumingthatthespace
group was P43212, but the model could not be properly reﬁned.
A standard statistical test of the structure factors revealed that
the correct space group is P43 with the twinning law h, -k, -l.
The law was introduced in the program Phenix.reﬁne [29] and
the model was reﬁned to give the statistics listed in Table 1.
The asymmetric unit contains four Bcl-xL protomers organized
as dimers that exhibit domain swapping, exchanging their N-
terminal α1-helix (Figure 3A). This kind of domain swapping has
been observed in several co-crystals of BH3 domains and human
Bcl-xL ( 27–82) [13,37–39]. It is considered to be an artifact
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Figure3 CrystalstructureoftheSOULBH3domainpeptidecomplexedwith
Bcl-xL
(A) A dimer of human Bcl-xL ( 27–82) showing swapping of the α1 domains. The two helical
SOULBH3peptidesarerepresentedinred.(B)AprotomerofBcl-xLandtheSOULBH3peptide
in contact with it. The portion of the peptide predicted by sequence homology to be the BH3
domainisinblue,whereastheyellowpartistheadditionalportionofthepeptide,thebeginning
of the second helix of SOUL. (C) Electron density of the SOUL BH3 peptide bound to Bcl-xL
oriented as in (B). The molecular surface of Bcl-xL shows the negatively charged residues in
red and those positively charged in blue. The 2Fobs −Fc map was contoured at a 1.2 σ level.
Selected BH3 peptide amino acids participating in important contacts with Bcl-xL have been
labelledinsingle-letteraminoacidnotation.TheFigurewaspreparedusingtheprogramPyMOL
(http://www.pymol.org).
due to the  27–82 deletion, but it does not affect in any way
the BH3-domain-binding activity or anti-apoptotic properties of
the protein. In fact, the complex in solution of the Beclin 1 BH3
domain and another truncated form of Bcl-xL studied by NMR
exhibits the same interactions observed in the crystals [40]. The
two dimers present in the asymmetric unit of the crystals of the
SOUL BH3 complex are very similar to each other, with an rmsd
(root mean square deviation) of 0.607 Å over 314 α carbon atoms
of Bcl-xL and the BH3 domains. Their Bcl-xL part is also quite
similartothatoftheotherdomain-swappeddimersofhumanBcl-
xL ( 27–82) that exchange the N-terminal α1-helix. The rmsd
values for the 276 α carbons are 1.845 Å for the Beclin 1 complex
([13];PDBcode2P1L),2.425ÅfortheBIML12Fmutantpeptide
complex ([38]; PDB code 3IO8) and 2.216 Å for the helical α/β
peptide foldamer complex ([39]; PDB code 3FDM).
ThestructuresofseveralBH3domainsincomplexwithBcl-xL
havebeenexamined.TheyallrevealthattheBH3sequenceforms
an amphipathic helix that inserts into a hydrophobic groove on
the surface of the anti-apoptotic protein [41–43].
The four SOUL BH3 domain peptides observed in the co-
crystals with Bcl-xL present an ordered structure which in every
case contains more amino acids at the N-terminus than those
predicted by sequence similarity (residues 158–172 of the SOUL
sequence). Of the 26-amino-acid-long peptide co-crystallized
with Bcl-xL, for only the ﬁrst three amino acids (Ser
147-Ala
148-
Gln
149)thereisnoclearelectrondensityinanyofthefourpeptides
present in the asymmetric unit. In all of the four BH3 domain
peptides examined, the helix observed is at least 18 amino acids
long (E
153QLLTLASILREDGKVFD
170). Figure 3(B) represents
in two colours the BH3 domain peptide bound to a protomer of
Bcl-xL that more closely corresponds to the prediction (chain
E). The extra amino acids at the N-terminus are represented in
a different colour. Figure 3(C) shows the electron density of the
BH3 domain peptide oriented as in Figure 3(B), with the Bcl-xL
protomer represented as a space-ﬁlling model. In intact SOUL,
the last amino acid of the second α-helix is Glu
164 and thus eight
aminoacidswiththesequenceDGKVFDEKintheloopfollowing
the helix change their conformation upon interaction with Bcl-xL
to become the last portion of the BH3 helical domain in the
complex.
The interactions of the SOUL BH3 domain peptide
with Bcl-xL are mostly hydrophobic (Supplementary Table
S1 at http://www.BiochemJ.org/bj/438/bj4380291add.htm, and
Figure 4), but they also include other more speciﬁc contacts, due
to charged residues: Gln
154 (BH3)–Gln
111 (Bcl-xL), Ser
160 (BH3)–
Glu
129 (Bcl-xL), Arg
163 (BH3)–Glu
129 (Bcl-xL), Asp
165 (BH3)–
Tyr
101 (Bcl-xL) and Asp
170 (BH3)–Tyr
195 (Bcl-xL). Residues
participating in hydrophobic contacts are Leu
155,L e u
156,L e u
158,
Leu
162 and Phe
172 of the BH3 domain peptide and Leu
108,L e u
112,
Leu
130,V a l
126,V a l
141,P h e
97,P h e
105,T y r
101,T y r
195 and Trp
137 of the
Bcl-xL molecule.
The amino acid contributions to the free energy of binding
of BH3 peptides to Bcl-xL have been calculated using
molecular dynamics simulations coupled with the molecular
mechanics/Poisson–Boltzmann surface area method [12]. The
Bcl-xL residues that give important contributions are: Phe
97,
Tyr
101,L e u
112,V a l
126,L e u
130,A r g
139,T y r
185 and Phe
146. With the
exceptionofthelastresidue,theyallparticipateintheinteractions
with the SOUL BH3 domain peptide. Leu
158 and Leu
162 of SOUL
BH3 correspond to Leu
112 and Leu
116 of Beclin 1 [13] and to
Ile
90 and Leu
94 of BIM [43], and Phe
169 corresponds to Phe
123 in
Beclin 1 and Phe
101 in BIM. Arg
163 of the SOUL BH3 domain
peptide, one of the residues controlling the speciﬁcity of binding,
corresponds to Lys
117 in Beclin 1 and Arg
95 in BIM. These three
basic amino acids are hydrogen-bond donors to Glu
129 of Bcl-xL.
Two of the speciﬁc charged residue contacts of the SOUL
BH3 domain peptide and Bcl-xL are represented in Figures 4(A)
and 4(B). They involve Arg
163 and Asp
170 of the BH3 domain
peptide. The ﬁrst interaction is established with Glu
129 of Bcl-xL,
whereas the second is with Tyr
195. Analogous contacts are found
in both Beclin 1 and BIM. The sequence of the peptide is aligned
to those of several well-known BH3-only proteins in Figure 4(C).
NotethatsomeaminoacidsintheN-terminalregionofthepeptide
are also present in other members of the family.
Figure 5(A) superimposes the domain in intact SOUL with
the helical conformation bound to Bcl-xL found in the crystals.
It is evident that very drastic changes are required to transform
the structure of the free domain into the bound one. Figure 5(B)
shows that binding of the BH3 domain peptide of SOUL to Bcl-
xL ( 27–82) is quite similar to the binding of another recognized
BH3 domain protein Beclin 1. Only one important contact is
missing in SOUL, that of an asparagine residue (Asp
121 in Beclin
1) with Arg
139 of Bcl-xL, which is conserved in all of the BH3
domain peptides studied so far. The absence of this interaction in
SOUL might explain the relatively high dissociation constant we
have observed for this complex.
DISCUSSION
The BH3-only members of the Bcl-2 protein family play a
central role in the process that leads to programmed cell death
or apoptosis. Their effect is due to inhibition through binding of
their BH3 domain in the hydrophobic cleft of the anti-apoptotic
members of the Bcl-2 family, such as Bcl-2, Bcl-xL or MCL-1.
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Figure 4 SOUL BH3 peptide side chains that interact with Bcl-xL
(A)A r g 163 and other side chains participating in one of the speciﬁc contacts of the SOUL BH3 peptide with Bcl-xL. Hydrogen bonds are indicated with green broken lines, whereas the amino acids
that make hydrophobic contacts are only indicated but not represented as ball and stick models. (B) The same type of diagram as (A), but with another speciﬁc contact in which the key residue is
Asp170 of the SOUL BH3 peptide. (C) Sequence alignment of the SOUL BH3 peptide and eight BH3-only proteins. The BH3 domains are boxed and the amino acids that are identical in SOUL and at
least two other sequencesarein red, whereasthose that areidentical in at least threesequencesarein blue. Theleucine residueconservedin all of the sequencesis indicated on a green background.
(A and B) were prepared using the visualization program LIGPLOT [49].
Indeed, one of the criteria to include a protein in this group is
a demonstration of its interaction with one of the pro-survival
proteins of the Bcl-2 family, in addition to showing that they have
a cellular death-inducing activity. On the basis of these criteria,
since the discovery of the ﬁrst member of the family, BIK [44],
many other members have been added to the list [9,10]. In many
cases, the proteins seem to have additional functions besides their
role in inducing cellular death. Although a very large number
of complexes of BH3 peptides with pro-survival proteins of the
Bcl-2 family are available [12,45], only one NMR structure of an
intact BH3-only protein is known, BID [46,47].
Two different mutually non-excluding functions have been
attributed to SOUL: haem transport [19] and a role in apoptosis
as a BH3-only protein [20,21]. We have used NMR, SPR, UV
spectroscopy and crystallography to explore both functions and,
inaddition,wehavedeterminedthethree-dimensionalstructureof
theprotein.HumanSOULisamonomerwithafoldwhichisquite
different from that of the other BH3-only protein whose three-
dimensional structure is known, BID, which is similar to Bcl-xL.
BID contains eight α-helices: two central hydrophobic helices
surrounded by six amphipathic helices with their hydrophilic face
exposed to the solvent. The SOUL molecule is similar to murine
p22HBP [33,34].
The interaction of human SOUL with haemin was explored by
titratingthelatterwiththeformerandfollowingtheUVspectrum,
using BSA as a control. In our experiments, we made sure that the
proteinuseddidnotcontainanytracesofthehistidinetagusedfor
puriﬁcation and that no imidazole, residual from the puriﬁcation
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Figure 5 Structural changes in the BH3 peptide of SOUL upon binding to
Bcl-xL
(A) Comparison of the peptide bound to Bcl-xL ( 27–82) (blue) and the same sequence in the
intact SOUL molecule (red). Eight amino acids change their conformation to extend the BH3
helix towards its C-terminus. The co-ordinates were superimposed by using the CCP4 suit of
programs. Three charged amino acids that give speciﬁcity to the interaction are represented
as stick models in the two conformations. (B) Superposition of the SOUL BH3 peptide Bcl-xL
( 27–82) complex (the peptide is in yellow and Bcl-xL is in orange) and the same complex of
Bcl-xL(inlightblue)andtheBeclin1BH3peptide(ingreen).ThePDBcodeofthemodelofthe
Beclin 1 peptide complex is 2P1L [13]. The interactions of the SOUL amino acids Arg163 and
Asp170 (shown in Figure 4) are indicated with dotted lines. The aspartate residue is conserved
in Beclin 1 and the equivalent of the arginine residue is a lysine. Note that the important contact
of Arg139 of Bcl-xL with an aspartate residue in Beclin 1 (conserved in all BH3 domain–Bcl-xL
complexes) is missing in the SOUL peptide.
intheafﬁnitycolumns,waspresentinthesamples.Wedidnotﬁnd
any evidence of an interaction between haemin and SOUL. This
result was conﬁrmed by the
15N-
1H HSQC NMR spectra of
15N-
labelled SOUL in the presence of increasing amounts of haemin.
We do not have an explanation as to why our results appear to be
at variance with those reported for mouse SOUL [19]. The latter
is reported to be a dimer in the absence of haem and a hexamer
in the bound state, which is different from both the results of the
present study and work on the related p22HBP proteins. It is also
worth noting that the histidine residue that Sato et al. [19] found
to be essential for haem binding does not seem to be involved
in haem binding to p22HBP, which appears to bind this moiety
through hydrophobic interactions and not metal co-ordination.
The interaction of a peptide spanning residues 147–172 of
human SOUL with human Bcl-xL was also studied with
15N-
1H HSQC NMR spectroscopy using two different forms of
human Bcl-xL, the entire molecule lacking only the hydrophobic
transmembrane domain after amino acid 209 and another
truncated form lacking also amino acids 27–82 ( 27–82). The
results were comparable and indicated in both cases that there is
an interaction of the 26-amino-acid SOUL peptide with Bcl-xL
with a dissociation constant estimated to be 40–50 μM. These
results were conﬁrmed by SPR measurements and by preparing
co-crystals of the complex and solving their three-dimensional
structure. The new crystal structure revealed swapping of the ﬁrst
helix of the Bcl-xL dimer, a phenomenon associated with the
presenceofthe 27–82truncation.Theaminoacidsparticipating
in the interaction of the BH3 domain and protein were identiﬁed.
Theinteractionsaremostlyhydrophobic,butasigniﬁcantnumber
ofspeciﬁcchargedresiduecontactswerealsofoundtobepresent.
When the SPR experiments performed to detect the interaction
of the SOUL BH3 domain peptide were repeated using the entire
SOUL molecule instead, no interaction was detected between
ligand and analyte. This result might be explained by the fact
that our ﬁndings predict a very drastic conformational change in
the protein molecule to allow the portion of polypeptide chain
involved in the contacts to adopt the conformation required for
the contacts to be established. The last eight amino acids of the
BH3 domain are not in a helical conformation in intact SOUL
and, in addition, side chains that are important for the interaction
point towards the interior of the molecule and are not available on
the protein surface. Conformational changes in the anti-apoptotic
members of the Bcl-2 family upon interaction with BH3 domains
have been described [38], as well as changes in the interacting
BH3 domains [41,46]. In addition, it has been shown that Bim,
Bad and Bmf have intrinsically unstructured BH3 domains that
undergo a localized conformational change upon binding to pro-
survival Bcl-2 targets [48]. No important changes were found
in Bcl-xL, but the changes in the BH3 domain are remarkable
and are sufﬁcient to explain why no interaction is observed with
the intact SOUL molecule. These drastic modiﬁcations might
require conditions that have not yet been found, but that should
be explored further given the importance of this interaction in the
functionality of the two proteins.
The mechanism of activation of BID, the prototype of BH3-
only proteins, involves cleavage by caspase 8 in a region with the
sequence LQTDG [46]. The second amino acid in the sequence
can be an glutamate residue and the last can be any amino acid
otherthanphenylalanine,glutamate,glutamine,lysineorarginine.
This cleavage site is not present in SOUL, although the similar
sequence LESDV spans residues 123–127 and is exposed to the
solvent in the molecule, in the loop connecting strand D to E.
However, an experiment with caspase 8, using human BID as a
control, revealed that SOUL is not a substrate of this enzyme
(results not shown).
The role of SOUL in inducing apoptosis has been documented,
butuptonowtherehasbeennoinformationatthemolecularlevel
on the mechanism through which this function is accomplished.
We have shown that its BH3 domain interacts with a pro-
survival member of the Bcl-2 family and thus we have provided
new evidence that SOUL behaves like a novel member of the
expanding family of BH3-only proteins.
Two very important questions remain unanswered: (i) the
nature of the molecular alteration that intact SOUL must undergo
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for the interaction to take place, and (ii) the precise speciﬁcity of
the interaction of the SOUL BH3 domain with different members
of the Bcl-2 family.
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SUPPLEMENTARY INFORMATION
X-ray structure of human SOUL
For the sake of simplicity, only the structure of the orthorhombic
crystal form which diffracts to 1.6 Å resolution was described
(in the main paper). At the end of this section, we will discuss
a difference that was found in the hexagonal crystal form solved
to 2.85 Å resolution. The ﬁnal model of the orthorhombic crystal
form of SOUL comprises 180 amino acid residues of both chains
A and B, the two monomers present in the asymmetric unit
of this crystal form. The maps do not show electron density
for the ﬁrst 18 residues and the last seven residues of both
chains. The model contains 2974 non-hydrogen protein atoms,
one phosphate and 395 water molecules. The conventional R
factor is 17.5% and the free R factor is 19.7% (see Table 1 in the
main paper). The R factors and rmsd values of Table 1 in the main
paper were calculated with the program Phenix.reﬁne [1]. The
stereochemical qualityof theproteinmodelwas assessedwith the
program PROCHECK [2]; 93.5% of the residues are in the most
favourable region of the Ramachandran plot and the remaining
6.5% in the additionally allowed region. The two molecules in
theasymmetricunitarenotrelatedbyanon-crystallographicdyad
and there are some minor differences between the two chains that
can be explained by the packing of the molecules in the crystal
(see below). The rmsd between the two main chains is 0.72 Å
calculated over 180 Cα pairs of equivalent residues.
The resolution of the orthorhombic crystal form is quite
adequate for the analysis of the structure of the solvent molecules
within the β-barrel cavity of the protein (see Table 1 of the main
paper),andwehaveidentiﬁedthewatermoleculesthatbindinthe
interiorofbarrelinthesamepositioninthetwoSOULmonomers
of the asymmetric unit. Trp
48 binds a water molecule at its NE1
atom, and another water molecule, in the proximity of the ﬁrst,
binds the NH1 atom of Arg
132. Two other water molecules, in the
proximity of the ﬁrst two, bind the carbonyls of Ala
133 and Gly
44,
the latter is external to the cavity. The four water molecules are
close enough so that the group should be described as a cluster
organized in a net of hydrogen-bonded solvent molecules. There
is another cluster that involves three conserved water molecules
positioned in the interior of the barrel (bound to the OG1 of
Thr
176 and the carbonyl of Val
89), at the interface (bound to the
carbonyl of Ser
181) and outside (bound to the water molecule
at the interface). Two other internal water molecules bridge the
OG1 of Thr
186 with the carbonyl of Lys
84 and the N of Tyr
110,a n d
anotherpairisboundtothecarboxymoietyofAsp
130.Thesolv ent
molecules in the interior of the cavity are in contact with others at
theinterfacewhichinturnareintheproximityofwatermolecules
in conserved positions on the external surface of SOUL.
An interesting structural difference was observed in the
hexagonal crystal form that diffracts to 2.85 Å and contains four
SOULmonomersintheasymmetricunit.Twoofthesemonomers
(A and B) swap the ﬁrst portion of their polypeptide chains, the
portion running from amino acids 19 to 32, i.e. before the ﬁrst
strand of β-sheet. This structure swapping is not conﬁrmed in
the other two monomers, since the portion where it is expected
to take place is disordered in the maps. This disorder is a clear
indicationofhighﬂexibilityofthatloopandwehavenotattributed
any particular signiﬁcance to our observation that we think is a
consequence of the molecular packing in the crystals.
Comparison of SOUL with HEBP1
The p22HBPs have been studied more extensively than the
SOUL family. They are ubiquitously expressed but are extremely
abundant in liver, have a cytoplasmic location and there is
solid evidence that they bind haem and several porphyrins with
micromolar Kd values [3]. The p22HBPs are highly homologous,
monomeric and soluble, and bind metalloporphyrins, free
porphyrins and N-methylprotoporphyrin with similar afﬁnities.
Two NMR structures of the same protein, murine p22HBP, have
been published [4,5]. In both models, the 22-kDa monomer is
described to fold as a distorted β-barrel ﬂanked by two long α-
helices arranged on one face. Using a
15N-
1H HSQC titration
experiment, the porphyrin-binding site of murine p22HBP was
mapped and found to comprise a number of loops and one of
the two α-helices with all of the residues participating in ligand
binding located on a single face of the molecule [5].
Murine p22HBP has approximately 28% sequence identity
with murine SOUL, which was reported to be a dimer in its apo
form and to hexamerize upon haem binding with a dissociation
constant in the nanomolar range [6]. It was reported further that
His
42, the only histidine residue present in the sequence, plays
a crucial role and that its mutation abolishes haem binding.
Comparison of ligand binding of murine p22HBP and murine
SOUL reveals that binding has to take place in very different sites
and therefore one has to confront the intriguing situation of two
highly similar proteins binding the same ligand in a very different
way.
The percentage of sequence identity between human SOUL
and murine p22HBP is approximately 29%, which supports the
predictionthatthetwofoldsshouldbeverysimilartooneanother.
In spite of this, all our attempts to solve the crystal structure of
SOUL by molecular replacement, using the two available NMR
structures as search probes, failed and the SOUL structure had to
be solved using the alternative single isomorphous replacement
method.
1 To whom correspondence should be addressed (email monaco@sci.univr.it).
The co-ordinates of the models, and the structure factors of SOUL and of the complex of human Bcl-xL with the peptide have been deposited in the
PDB under accession codes 3R85, 3R8J and 3R8K.
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After the ﬁnal co-ordinates of SOUL became available, the
model of chain A of SOUL was superimposed to that of chain B
and the two lowest energy NMR structures available of murine
p22HBP (PDB codes 2GOV and 2HVA; [4,5]), and the distances
between equivalent α carbons were calculated. The results are
represented in Supplementary Figure S1(A) as a function of
the amino acid number. In the Figure the blue trace represents
the differences between the two SOUL molecule models in the
orthorhombic crystal asymmetric unit (A and B) and the black
trace indicates the difference between the two murine p22HBP
NMR structures. The area where the two SOUL molecules in
the asymmetric unit differ more are the region before the ﬁrst
strand of β-sheet and the loop connecting strands C and D. The
chains before the ﬁrst strand are totally exposed to the solvent,
whereas in the case of the connection of strands C and D the
loop in chain A is in close contact with a symmetry related
molecule and the equivalent area is in contact with the solvent
in molecule B. We thus believe that these differences are simply a
consequence of molecular packing in the crystal. Although there
is more variability in the two NMR structures of murine p22HBP,
thetwostructuresareverysimilarintheregionconnectingstrands
C and D, which is also the region where both are most different
from SOUL. This particular region of the SOUL molecule thus
appears to be more variable than the rest of the molecule
SupplementaryFigureS1(B)isastereopairinwhichthemodel
of SOUL A is superimposed to the two NMR models of murine
p22HBP. In the Figure, SOUL is represented in blue, whereas the
twomodelsofmurinep22HBPareinredandgreen.AstheFigure
shows there are areas of larger variability in the conformation of
the proteins. The N-terminal region of the two NMR structures
is very different and both differ substantially from the X-ray
structure, which is due to the fact that this part of the chain
is very ﬂexible and becomes more structured in the crystals. A
more signiﬁcant difference is observed in the loop connecting
strands C and D between the A chain of SOUL and the two NMR
structures. This area of the molecule is, however, in different
conformationsinthetwoSOULmoleculesoftheasymmetricunit
and so the differences observed with murine p22HBP probably
simply reﬂect the high degree of ﬂexibility of this area.
Overall the three structures are quite similar, although, as
expected, the differences between the two NMR structures are
somewhat smaller than those observed between them and the
crystal structure of SOUL.
Table S1 Main contacts between the SOUL BH3 domain and human Bcl-xL
Selected distances between the closest human Bcl-xL residues of molecule A and the SOUL
BH3 domain in contact with it (labelled molecule E). The hydrophilic contacts are highlighted
in bold
SOUL residue Atom Bcl-xL residue Atom Distance (A ˚)
Glu153 OE1 Gln111 O4 . 4 5
Gln154 NE2 Gln111 OE1 2.66
Gln154 CD Gln111 CD 4.18
Leu155 CB Gln111 CB 3.67
Leu155 CG Leu112 CD2 4.00
Leu155 CD1 Val126 CG2 4.13
Leu156 CD1 Glu129 CG 3.76
Leu158 CD1 Gln111 CG 3.51
Leu158 CD1 Leu108 CD1 4.78
Leu158 CD1 Asp107 CB 4.13
Ala159 CB Val126 CB 4.26
Ser160 OG Glu129 OE2 3.81
Leu162 CB Leu130 CD1 3.76
Leu162 CD1 Ala142 CB 4.18
Leu162 CD1 Phe97 CZ 3.67
Leu162 CG Phe105 CZ 4.88
Leu162 CD2 Leu108 CD2 4.30
Arg163 NH2 Asp133 OD2 4.02
Arg163 NH1 Glu129 OE2 3.13
Arg163 OA r g 139 NH2 3.26
Arg163 CG Arg139 CZ 3.63
Arg163 CG Arg139 CD 3.75
Arg163 CB Leu130 CD1 4.16
Glu164 NA r g 139 NE 4.74
Asp165 OD1 Tyr101 OH 3.96
Asp165 CB Phe97 CZ 4.11
Asp165 CB Tyr101 CD1 3.85
Gly166 O Asn136 OD1 4.05
Gly166 CG l y 138 C4 . 0 7
Gly166 CA Arg139 CG 3.73
Gly166 CG l y 138 C4 . 0 7
Lys167 CB Arg139 CZ 3.85
Lys167 CB Asn136 CG 4.90
Lys167 O Asn136 ND2 4.59
Val168 CB Tyr101 CZ 4.97
Phe169 CD1 Phe97 CD2 3.54
Phe169 CZ Tyr195 CE2 4.07
Phe169 CE2 Val141 CG2 3.87
Phe169 CE2 Ala93 CB 4.53
Asp170 OD1 Tyr195 OH 2.44
Asp170 OD2 Asn136 ND2 3.25
Asp170 OD1 Gly138 N3 . 0 6
Asp170 OD2 Trp137 N4 . 0 9
Asp170 CG Trp137 C4 . 8 8
Asp170 CG Asn136 CB 4.50
Lys172 CD Tyr195 CE2 4.19
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Figure S1 Comparison of the models of human SOUL and murine p22HBP
(A)rsmdbetweenα-carbonatomsoftheSOULmodelsandthemodelsofmurinep22HBP:AchaincomparedwithBchainoftheorthorhombicform(blue);lowestenergyNMRmurinestructure(PDB
code 2GOV) compared with the other equivalent structure available of the same protein (PDB code 2HVA) (black). The green and red traces compare chain A of SOUL with the two NMR structures
of murine p22HBP [PDB codes 2GOV (green) and 2HVA (red)]. The strip at the bottom of the Figure represents the elements of secondary structure of SOUL. The blue colour identiﬁes the buried
residues, whereas white is used to indicate the exposed amino acids. (B) Stereoimage with the superposition of the three models. SOUL is in blue and the two NMR models of murine p22HBP are in
red and green. The Figures of the models were prepared using the program PyMOL (http://www.pymol.org).
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Figure S2 Interaction of SOUL with haemin
(A)UV–visiblespectraofhaeminalone(brokenline)andwithtentimesamolarexcessofSOUL
(dotted line) and BSA (solid line). (B) HSQC titration of 15N-labelled SOUL with haemin. The
blackspectrumcorrespondstoproteinSOULbeforethetitration,whereastheredspectrumwas
recorded after the addition of four equivalents of haemin. No differences were detected between
the two spectra.
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